Marc Blaustein

Marc Blaustein

Plus aucun poste en cours
63 ans
Health Technology
Consumer Services
Health Services

Profil

Marc B. Blaustein is the founder of Akashi Therapeutics Inc, which was founded in 2011.
He held the title of Chief Executive Officer from 2011 to 2017.
Mr. Blaustein's former jobs include being the Chief Executive Officer of Ned Biosystems, Inc. from 2017 to 2019, Head of Business Development at Genetics Institute LLC, Senior Vice President of Manufacturing, Process & Commercial Operations at Dyax Corp.
from 2006 to 2009, Chief Operating, Financial & Accounting Officer at Finch Therapeutics Group, Inc. from 2022 to 2023, and Head of Business Development at Guide Therapeutics, Inc. from 2019 to 2021.
He is also a Founding Partner at Northbridge Consulting.
Mr. Blaustein's education includes a graduate degree from Harvard University and an undergraduate degree from the University of Pennsylvania.

Anciens postes connus de Marc Blaustein

SociétésPosteFin
FINCH THERAPEUTICS GROUP, INC. Directeur Financier/CFO 15/05/2023
Corporate Officer/Principal 01/01/2021
Directeur Général 01/01/2019
Directeur Général 01/01/2017
DYAX CORP. Corporate Officer/Principal 01/01/2009
Voir l'expérience en détail de Marc Blaustein

Formation de Marc Blaustein

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

30

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

Northbridge Consulting

  1. Bourse
  2. Insiders
  3. Marc Blaustein
🔇